Countries Australia

Clarity's theranostic prostate cancer trial progresses at the highest dose level cohort

Cohort 3 of the theranostic SECuRE trial investigating 64Cu/67Cu-SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has enrolled a...

 November 30, 2023 | News

Merz Therapeutics Receives TGA Approval for XEOMIN® in Australia

This marks a significant milestone as XEOMIN® is the first approved neurotoxin for the treatment of this condition in the Australian market. Addit...

 November 23, 2023 | News

Prospection AI Launches Single-source Patient-centric Platform in Australia to Boost Drug Commercialization

-Prospection—the pioneer of patient-centric intelligence—today announced the availability of Prospection AI, its self-service patient-cent...

 November 21, 2023 | News

Telix, an Australian Company, Announces Planned Acquisition of QSAM Biosciences and its Lead Therapy Candidate, CycloSam

CycloSam® is highly synergistic with Telix's existing therapeutic development activity in both prostate cancer and sarcoma. The proposed acquisiti...

 November 14, 2023 | News

George Clinical and Medidata Partner in Australia to Boost Operational Efficiency in Clinical Trials

Medidata, a Dassault Systèmes company, announced that George Clinical, a leading global clinical research organization, is leveraging Medidata's clo...

 November 14, 2023 | News

P&G's Gillette and Braun Join Forces with Movember to Tackle Men's Health Crisis in Australia

In Australia, one in five men will be diagnosed with prostate cancer in their lifetime. One man globally dies by suicide every minute. Testicular cancer is...

 November 13, 2023 | News

AdvanCell Doses First Patient in 212Pb-ADVC001 Clinical Trial for Metastatic Prostate Cancer in Australia

“The first patient dosed with an AdvanCell therapeutic candidate represents a major milestone for the Company, our scientists, clinical trial sites, ...

 November 09, 2023 | News

The Resilience and Growth of Australia's Pharmaceutical Manufacturing Industry: A Glimpse into the Future

Historical Context Australia has a long history of pharmaceutical manufacturing dating back to the early 20th century. The industry primarily focused on t...

 November 08, 2023 | Analysis

PolyActiva Reports Positive Glaucoma Implant Trial in Australia

  Melbourne ophthalmology company PolyActiva is developing a unique biodegradable ocular implant that provides 6 months of sustained drug deli...

 November 06, 2023 | News

New report quantifies the impact of R&D Tax Incentive (RDTI) in Australia’s life sciences sector

The newly-launched ‘Economic impact of the Research & Development Tax Incentive for the biotech industry’, report has quantified the far-re...

 November 01, 2023 | News

AusBiotech 2023 kicks off in Brisbane with 1,200 delegates representing global life science ecosystem

Held in Brisbane from 1-3 November, Australia’s biggest week in biotech features its flagship event, AusBiotech 2023, which today launches with more ...

 November 01, 2023 | News

AusBioInvest 2023 marks beginning of Australia’s biggest week in biotech

 Australia’s biggest week is officially underway, with AusBioInvest 2023 kicking off today in Melbourne to an audience of investors and life sci...

 October 30, 2023 | News

Australia's Certa Therapeutics: FT011 Granted US FDA Orphan Drug Status for Systemic Sclerosis

Orphan Drug Designation is granted by the FDA to investigational therapies addressing rare medical diseases or conditions that affect fewer than 200,000 pe...

 October 24, 2023 | News

Avance Clinical Briefs 45 Korean Biotechs on Global Drug Development

Dt & SanoMedics Chairman, Charles Park (Park, Chae Gyoo) and Avance Clinical CEO Yvonne Lungershausen co-hosting the Global Clinical Trial Strategy...

 October 23, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in